M V Putilina Selected Research

Brain Diseases (Brain Disorder)

1/2021	Direct and Indirect Neurological Signs of COVID-19.
1/2020	[Direct and indirect neurological manifestations of COVID-19].
1/2010	[Diagnosis and therapy of mild and moderate cognitive disorders in elderly patients with hypertonic encephalopathy].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M V Putilina Research Topics

Disease

5	Brain Ischemia (Cerebral Ischemia) 01/2024 - 01/2020
5	COVID-19 01/2021 - 01/2020
3	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2022 - 01/2016
3	Nervous System Diseases (Neurological Disorders) 01/2022 - 01/2021
3	Brain Diseases (Brain Disorder) 01/2021 - 01/2010
3	Inflammation (Inflammations) 01/2021 - 01/2020
2	Sleep Wake Disorders 01/2024 - 01/2022
2	Disease Progression 01/2024 - 01/2021
2	Pain (Aches) 01/2022 - 01/2020
2	Ageusia (Hypogeusia) 01/2021 - 01/2020
2	Anosmia 01/2021 - 01/2020
2	Neuroinflammatory Diseases 01/2021 - 01/2020
2	Demyelinating Diseases (Demyelinating Disease) 01/2021 - 01/2020
2	Fibrosis (Cirrhosis) 01/2021 - 01/2020
2	Ischemia 01/2021 - 01/2020
2	Neurologic Manifestations (Neurological Manifestations) 01/2021 - 01/2020
2	Cognitive Dysfunction 01/2021 - 01/2010
2	Dystonia (Limb Dystonia) 01/2004 - 01/2004
1	Disorders of Excessive Somnolence (Hypersomnia) 01/2024
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2024
1	Diabetic Neuropathies (Diabetic Neuropathy) 01/2024
1	Chronic Pain 01/2023
1	Ischemic Stroke 01/2022
1	Infections 01/2021
1	Thrombocytopenia (Thrombopenia) 01/2021
1	Muscle Cramp (Cramp) 01/2020
1	Sacroiliitis 01/2020
1	Vertigo (Positional Vertigo) 01/2014
1	PICA syndrome 01/2011
1	Hypertensive Encephalopathy 01/2008

Drug/Important Bio-Agent (IBA)

4	cortexinIBA 01/2024 - 01/2022
3	Choline (Choline Chloride)IBA 01/2023 - 01/2020
3	Nerve Growth Factors (Neurotrophins)IBA 01/2021 - 01/2020
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2022 - 01/2020
2	fibrin fragment D (D-dimer)IBA 01/2021 - 01/2020
2	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2021 - 01/2020
2	Antiviral Agents (Antivirals)IBA 01/2021 - 01/2020
2	Dipyridamole (Persantine)FDA LinkGeneric 01/2021 - 01/2020
2	Dopamine (Intropin)FDA LinkGeneric 01/2021 - 01/2020
2	EnkephalinsIBA 01/2021 - 01/2020
2	gamma-Aminobutyric Acid (GABA)IBA 01/2021 - 01/2020
2	Serotonin (5 Hydroxytryptamine)IBA 01/2021 - 01/2020
2	CytokinesIBA 01/2021 - 01/2020
2	Neurotransmitter Agents (Neurotransmitter)IBA 01/2021 - 01/2020
2	MicronutrientsIBA 01/2021 - 01/2020
2	emoxypine succinateIBA 01/2016 - 01/2011
2	vinpocetineIBA 01/2014 - 01/2008
2	Betahistine (Serc)IBA 01/2004 - 01/2004
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2024
1	Vitamin B Complex (B Vitamins)IBA 01/2023
1	Inosine FDA Link 01/2023
1	RivaroxabanIBA 01/2022
1	Peptides (Polypeptides)IBA 01/2022
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022
1	Cholinergic Agents (Cholinergics)IBA 01/2021
1	cytoflavinIBA 01/2021
1	Glycerylphosphorylcholine (Choline Alfoscerate)IBA 01/2020
1	CytidineIBA 01/2020
1	Cytidine Diphosphate Choline (Citicoline)IBA 01/2020
1	Oxidants (Oxidizing Agents)IBA 01/2011

Therapy/Procedure

11	Therapeutics 01/2024 - 01/2010
2	Neurological Rehabilitation 01/2021 - 01/2020